Anne Prener

Director, Rubius Therapeutics (United States).

Companies

Keros Therapeutics, Inc.Board member Jul 6, 2026 to now¹
Damora Therapeutics, Inc.Board member Jan 8, 2021 to now²
Rubius Therapeutics (United States)Board member Dec 26, 2019 to May 13, 2022³
Kaleido Biosciences, Inc.Board member Apr 3, 2020 to Jul 1, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Keros Therapeutics, Inc. KROS13,786 shares⁵$152.2K at $11.04Jul 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 1, 2026Granted 13,786 shares of Keros Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKeros Therapeutics, Inc., Board member
2
SEC EDGARDamora Therapeutics, Inc., Board member
3
SEC EDGARRubius Therapeutics (United States), Board member
4
SEC EDGARKaleido Biosciences, Inc., Board member
5
SEC EDGARKeros Therapeutics, Inc. shares after the filing of Jul 1, 2026